Form 8-K - Current report:
SEC Accession No. 0001493152-16-014737
Filing Date
2016-11-10
Accepted
2016-11-10 16:18:38
Documents
8
Period of Report
2016-11-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 26790
2 ex99-1.htm EX-99.1 65255
3 image_001.jpg GRAPHIC 16818
4 image_002.jpg GRAPHIC 4684
5 image_003.jpg GRAPHIC 4462
6 image_004.jpg GRAPHIC 14734
7 image_005.jpg GRAPHIC 16683
8 image_006.jpg GRAPHIC 15077
  Complete submission text file 0001493152-16-014737.txt   193810
Mailing Address 100 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 100 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001595097 (see all company filings)

EIN.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37348 | Film No.: 161988292
SIC: 2834 Pharmaceutical Preparations